Advertisement

Topics

ImmunoVaccine Technologies Inc Company Profile

23:57 EDT 21st June 2018 | BioPortfolio

ImmunoVaccine Technologies Inc. (IVT) is a company based in Halifax, Nova Scotia, Canada, commercializing a proprietary vaccine technology, VacciMax®.Proprietary Vaccine Enhancement Technology .ImmunoVaccine Technologies, Inc. (IVT) is the owner of the patented VacciMax® Platform that delivers long duration of immunity in a single administration, without boosting or significant side effects. The company is seeking additional partners in human vaccines for infectious diseases and cancer and in veterinary vaccines for infectious diseases and fertility control

Location

1819 Granville Street,Suite 303
Halifax
Nova Scotia
B3J 3R1
Canada

Contact

Phone: 902) 492-1819
Fax: (902) 492-0888
Email: info@immunovaccine.com


News Articles [226 Associated News Articles listed on BioPortfolio]

Immunovaccine`s Patented DepoVax Technology

In this episode of PharmaTelevision News Review, Fintan Walton talks to Vicki L. Morgan MBA, Director of Business Development, ImmunoVaccine Inc. They discuss: • Origins of Immunovaccine • Depova...

Immunovaccine: Delivering Breakthrough Vaccines

In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to John Trizzino, CEO of Immunovaccine.

Immunovaccine nets $Cdn13.5mm through bought deal offering

Immunovaccine Inc. (immuno-oncology) netted $Cdn13.5mm ($10.9mm) through a bought deal offering of 7.2mm common shares (including the overallotment) at $Cdn2. Proceeds will support continued developme...

Immunovaccine Named to 2018 OTCQX Best 50

HALIFAX, Nova Scotia, Jan. 24, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced that it has been named to the 2018 OT...

IMV Inc. (Formerly Immunovaccine Inc.) Announces Q1 2018 Financial Results

HALIFAX, Nova Scotia, May 14, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (TSX:IMV) (OTCQX:IMMVD), a clinical stage immuno-oncology corporation, today released its financial and operational results for the f...

Immunovaccine to Present at 2018 BIO CEO & Investor Conference

HALIFAX, Nova Scotia, Feb. 02, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology company, today announced it will participate in this year’s ...

Immunovaccine Shareholders Approve Share Consolidation at 99.85%

HALIFAX, Nova Scotia, May 01, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV)(OTCQX:IMMVF), a clinical stage immuno-oncology corporation, today announced that at the annual and special meet...

Immunovaccine Announces Year-End 2017 Financial Results

HALIFAX, Nova Scotia, March 20, 2018 (GLOBE NEWSWIRE) -- Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology corporation, today released its financial and operational res...

PubMed Articles [333 Associated PubMed Articles listed on BioPortfolio]

Three-dimensional Technologies in Orthopedics.

New 3-dimensional digital technologies are revolutionizing orthopedic clinical practice, allowing structures of any complexity to be manufactured in just hours. Such technologies can make surgery for ...

'Omic' technologies as a helpful tool in radioecological research.

This article presents a brief review of the modern 'omic' technologies, namely genomics, epigenomics, transcriptomics, proteomics, and metabolomics, as well as the examples of their possible use in ra...

On the Cusp of a Healthcare Revolution: BME Technologies Have the Potential to ?Transform Our World?

Of the key technologies listed as "ready to propel industries and transform our world" in the 2017 report Top 50 Emerging Technologies: Growth Opportunities of Strategic Imperative, most fall under th...

The state of knowledge on technologies and their use for fall detection: A scoping review.

Globally, populations are aging with increasing life spans. The normal aging process and the resulting disabilities increase fall risks. Falls are an important cause of injury, loss of independence an...

Economic evaluations of eHealth technologies: A systematic review.

Innovations in eHealth technologies have the potential to help older adults live independently, maintain their quality of life, and to reduce their health system dependency and health care expenditure...

Clinical Trials [395 Associated Clinical Trials listed on BioPortfolio]

Application of Monitoring and Intervention Technologies in Suboptimal Health Status

The purpose of this study is to use monitoring and intervention technologies in suboptimal health status in a general population in China and evaluate the effectiveness of these technologi...

Wheeze Detection in Adults During Dynamic Bronchial Situations Measured by PulmoTrack® 2010 With WIM-PC™ Technologies Recording

The PulmoTrack® 2010 with WIM-PC™ Technologies device, indicated for acoustic pulmonary function measurement that quantifies the presence of wheezing. This study was designed in order t...

Testing Latest Version of NidekRS3000Adv

The investigators would like to know if different imaging devices can improve the quality of images and visualization of imaged tissues. Also, the investigators would like to find out whet...

Objective Functional Outcome Measures in Orthopedic Surgery Using Advanced Tracking Technologies

The proposed project will address the measurement and ramifications of out-of-home mobility problems in various orthopedic disorders in an innovative way, using advanced tracking technolog...

Online Peer Networked Collaborative Learning for Managing Depressive Symptoms

The mission of this project is to develop novel systems of care that can provide efficacious, scalable, cost-effective, participant friendly technology assisted behavioral interventions (T...

Companies [1257 Associated Companies listed on BioPortfolio]

ImmunoVaccine Technologies Inc

ImmunoVaccine Technologies Inc. (IVT) is a company based in Halifax, Nova Scotia, Canada, commercializing a proprietary vaccine technology, VacciMax®.Proprietary Vaccine Enhancement Technology .Immun...

IMMUNOVACCINE TECHNOLOGIES INC.

Immunovaccine Inc.

Immunovaccine Inc. develops cancer immunotherapies and infectious disease vaccines based on the Company’s DepoVax™ platform, a patented formulation that provides control...

LVL Technologies, Inc.

LVL Technologies, Inc. was founded by Dr. Dustin Freckleton and Nithin Rajan with a mission of bringing the accuracy of medical device technologies to the consumer wearables marke...

CA Technologies

CA Technologies (NASDAQ: CA) is an IT management software and solutions company with expertise across all IT environments - from mainframe and distributed, to virtual and cloud. For additional inf...

More Information about "ImmunoVaccine Technologies Inc" on BioPortfolio

We have published hundreds of ImmunoVaccine Technologies Inc news stories on BioPortfolio along with dozens of ImmunoVaccine Technologies Inc Clinical Trials and PubMed Articles about ImmunoVaccine Technologies Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ImmunoVaccine Technologies Inc Companies in our database. You can also find out about relevant ImmunoVaccine Technologies Inc Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Vaccine
A vaccine is a biological preparation that improves immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism, and is often made from weakened or killed forms of the microbe, its toxins or one ...

Immunology
Allergies Automimmune Disease Human Papillomavirus (HPV) Immunology Vaccine Immunology is the study of immunity and the defence mechanisms of the body. A greater understanding of immunology is needed to develop vaccines, understand ...


Corporate Database Quicklinks



Searches Linking to this Company Record